Revenue grew on a comparable basis as results in its imaging and precision therapy business units offset currency and tariff headwinds.
Siemens Healthineers reported first-quarter operating profit above market expectations on Thursday, as strong margin performance in its core imaging and cancer-care units helped cushion a slump in its diagnostics business and adverse currency exchange rates.
Siemens Healthineers (SEMHF) is undervalued, offering strong safety and upside, and remains a top 'BUY' pick for 2026. Key risks center on muted China growth, but ex-China performance is robust, with Imaging and Varian segments driving future gains. I maintain my share price target, with fair value estimates, implying 15%+ annualized upside even with conservative assumptions.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Dr. Bernhard Montag Ph.D. CEO | OTC PINK Exchange | 82622J104 CUSIP |
| DE Country | 72,000 Employees | 20 Feb 2025 Last Dividend | - Last Split | - IPO Date |
Siemens Healthineers AG is a prominent company in the healthcare technology sector, providing a comprehensive range of diagnostic and therapeutic products and services to healthcare providers around the globe. The company operates under four main segments: Imaging, Diagnostics, Varian, and Advanced Therapies, catering to the diverse needs of medical facilities from diagnostic labs to oncology departments. With its subsidiaries, Siemens Healthineers is dedicated to enhancing the efficiency and outcomes of medical care through cutting-edge technology and services. Headquartered in Forchheim, Germany, it is a subsidiary of the global powerhouse, Siemens Aktiengesellschaft, affirming its strong position in the market by offering indispensable technical customer support and innovative healthcare solutions.
This segment delivers a variety of imaging equipment, including magnetic resonance imaging (MRI), computed tomography (CT), X-ray systems, molecular imaging, and ultrasound systems. These technologies are crucial for diagnosing and monitoring a wide array of conditions, enabling healthcare providers to offer precise and effective treatments.
The Diagnostics segment provides in-vitro diagnostic products and services, including laboratory and point-of-care diagnostics, along with workflow solutions for laboratories. This also encompasses informatics products, which integrate and manage laboratory data, facilitating more streamlined operations and improved patient outcomes.
Under this segment, Siemens Healthineers offers cutting-edge cancer care technologies, solutions, and services. This includes technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing cancer treatment and therapy, directly supporting oncology departments in hospitals and clinics.
Focused on supporting image-guided minimally invasive treatments, this segment offers products for areas including cardiology, interventional radiology, and surgery. Among the offerings are angiography systems and mobile C-arms, which are essential for a variety of therapeutic procedures.
Siemens Healthineers provides essential technical customer services that include maintenance and repair, medical equipment performance management, training, clinical education and e-learning, and more. Beyond these services, it offers planning and design, financing, asset management, and managed departmental services for laboratories and healthcare facilities. Digital healthcare consulting, products, and services are also a significant part of their offering, aimed at optimizing healthcare workflows and enhancing patient care through technological innovation.